BioCentury | Jan 8, 2021
Finance
Jan. 8 Quick Takes: Venture rounds for Abbisko, DiCE, Aulos, LifeMine, Mana, Theolytics and more
...promote IL-2’s immune activation effects while blocking its immunosuppressive activity.Cobro, Lightchain back Mana’s launchNewly launched Mana Therapeutics...
